Skip to main content

Peer Review reports

From: Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring

Original Submission
12 Nov 2013 Submitted Original manuscript
1 Dec 2013 Reviewed Reviewer Report - Dana Horakova
7 Dec 2013 Reviewed Reviewer Report - Ondrej Dolezal
15 Jan 2014 Author responded Author comments - Raed Alroughani
Resubmission - Version 2
15 Jan 2014 Submitted Manuscript version 2
6 Feb 2014 Author responded Author comments - Raed Alroughani
Resubmission - Version 3
6 Feb 2014 Submitted Manuscript version 3
Publishing
7 Feb 2014 Editorially accepted
12 Feb 2014 Article published 10.1186/1471-2377-14-27

You can find further information about peer review here.

Back to article page